ACTINIUM PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -33.7% | -33.7% | -30.8% |
| FY2022 | -49.7% | -49.7% | -28.9% |
| FY2023 | -134.2% | -134.2% | -59.9% |
| FY2024 | -116.7% | -116.7% | -49.7% |
| FY2025 | -432.6% | -432.6% | -65.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -33.7% | -33.7% | -30.8% |
| FY2022 | -49.7% | -49.7% | -28.9% |
| FY2023 | -134.2% | -134.2% | -59.9% |
| FY2024 | -116.7% | -116.7% | -49.7% |
| FY2025 | -432.6% | -432.6% | -65.5% |